Smart for Life, INC 8-K filings
Current reports — the filing a company makes when something happens that shareholders need to know about before the next quarterly report.
OTC.Pink
Smart for Life, Inc. filed a lawsuit seeking over $30 million from its former auditor for alleged negligence leading to its Nasdaq delisting, alongside multiple board resignations.
OTC.Pink
Smart for Life's Chief Financial Officer, Alan Bergman, resigned on December 9, 2024, with CEO Darren Minton taking on the additional role of CFO, amidst the company's delisting from Nasdaq.
OTC.Pink
Smart for Life, Inc. has dismissed its auditor, RBSM LLP, and engaged TAAD LLP, following its delisting from the Nasdaq Capital Market.
OTC.Pink
Smart for Life, Inc. has entered into an agreement to acquire Hyperion and OPM for $2.5 million, while also completing the sale of its subsidiary assets.
OTC.Pink
Smart for Life, Inc. will be delisted from the Nasdaq Capital Market effective September 19, 2024, due to non-compliance with listing requirements.
OTC.Pink
Smart for Life, Inc. is facing potential delisting from the Nasdaq due to ongoing non-compliance with listing rules, including equity requirements, failure to hold an annual meeting, and delinquent financial filings.
OTC.Pink
Smart for Life, Inc. has amended its asset purchase agreement and debt terms, including extending the option exercise date for the sale of its remaining stake in a subsidiary.
OTC.Pink
Smart for Life, Inc. issued new warrants for common stock after existing warrant holders exercised their options at a reduced price, resulting in net proceeds of approximately $458,473.
OTC.Pink
Smart for Life, Inc. is offering warrant holders an inducement to exercise their existing warrants at a reduced price, resulting in $779,322.50 in gross proceeds and the issuance of new warrants.
OTC.Pink
Smart for Life, Inc. is facing potential delisting from Nasdaq due to multiple compliance issues, including insufficient stockholders' equity, failure to hold an annual meeting, and delinquent financial filings.
OTC.Pink
Smart for Life, Inc. is facing potential delisting from the Nasdaq due to multiple compliance issues, including insufficient stockholders' equity, failure to hold an annual meeting, and a low share price.
OTC.Pink
Smart for Life, Inc. has appointed Heather Granato to its Board of Directors, filling the vacancy left by Robert S. Rein's resignation.
OTC.Pink
Smart for Life, Inc. is facing potential delisting from Nasdaq due to failing to meet the minimum stockholders' equity requirement, not holding an annual meeting, and being delinquent in filing its annual report.
OTC.Pink
Smart for Life, Inc. has agreed to acquire Purely Optimal Nutrition for approximately $11.9 million, consisting of cash and newly issued preferred stock.
OTC.Pink
Smart for Life, Inc. has appointed Loren Brown as an independent director, effective March 8, 2024, to fill a recent board vacancy and enhance its corporate governance.
OTC.Pink
Smart for Life, Inc. has created a new series of preferred stock and converted over $3 million of debt into equity, improving its balance sheet.
OTC.Pink
Roger Conley Wood resigned from the Board of Directors of Smart for Life, Inc. on February 22, 2024, with no reported disagreements with the company.
OTC.Pink
Smart for Life, Inc. has sold the assets of its subsidiaries Ceautamed, Wellness Watchers Global, and Greens First Female to First Health FL LLC, a newly formed entity.
OTC.Pink
Smart for Life, Inc. is facing potential delisting from the Nasdaq due to not meeting the minimum stockholders' equity requirement and failing to hold an annual shareholder meeting.